Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants

Description:

Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 2nd Edition builds on the same foundation of clearly explained, up-to-date, and clinically current content as the trusted Lehne undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically need for safe and effective prescribing. Three introductory chapters provide foundational content for new prescribers in the areas of prescriptive authority, rational drug selection, prescription writing, and promoting positive outcomes of drug therapy. Core drug chapters are focused on the drugs that prescribers will most commonly see in clinical practice.

Features:

• Introductory chapters tailored to the specific needs of prescribers cover topics such as prescriptive authority, rational drug selection and prescription writing, and promoting positive outcomes of drug therapy.
• Carefully focused pharmacotherapeutic content reflects the drugs most commonly seen and used by prescribers, with emphasis not on the first drug discovered or developed in each class but on the agents most often used today. Primary care drugs are addressed first in each chapter as appropriate, followed by acute care drugs.
• UNIQUE! Prescriber-focused pedagogical aids further reinforce the most important information for prescribers.
• Integrated coverage of Canadian trade names appears throughout the text and is highlighted with a familiar maple-leaf icon.
• Integrated coverage of interprofessional collaboration addresses the growing global interest in interprofessional collaboration and incorporates opportunities for interprofessional collaborative practice throughout.

New To This Edition:

• NEW! Genetic and Genomic Considerations chapter addresses our growing understanding of the importance of genetics and genomics in pharmacotherapeutic management of disease.
• NEW! Immunomodulators chapter covers the growing role of this innovative therapy in cancer treatment.
• NEW! Increased emphasis on the needs of prescribers includes new Key Prescribing Considerations specifically tailored for advanced practice nurses (APNs) and Physician Assistants (PAs), revised introductory disease content, and refocused illustrations.
• NEW! Expanded delineation of acute care drugs now extends to the cardiac, neurologic, hypertension, and male and female reproductive chapters.
• NEW! Significantly revised content on laboratory drug monitoring has been refocused on the needs of APNs and PAs
• NEW! Updated content on drug legislation, opioid addiction, and legalized marijuana addresses these key areas of change for prescribers.
• NEW! Illustrations, tables, and boxes have been substituted for text to highlight treatment guidelines (including decision-making algorithms) and drug mechanisms of action.
• NEW! Improved legibility includes the elimination of "small type" and a more user-friendly graphic design.
• NEW! Updated content covers the areas of drug legislation, opioid addiction, marijuana.

Table Of Contents:

UNIT I: INTRODUCTION

1. Prescriptive Authority

2. Rational Drug Selection and Prescription Writing

3. Promoting Positive Outcomes of Drug Therapy

UNIT II: BASIC PRINCIPLES OF PHARMACOLOGY

4. Pharmacokinetics, Pharmacodynamics, and Drug Interactions

5. Adverse Drug Reactions and Medication Errors

6. Individual Variation in Drug Responses

7. Genetic and Genomic Considerations in Pharmacotherapeutics NEW!

UNIT III: DRUG THERAPY ACROSS THE LIFE SPAN

8. Drug Therapy During Pregnancy and Breast-Feeding

9. Drug Therapy in Pediatric Patients

10. Drug Therapy in Geriatric Patients

UNIT IV: PERIPHERAL NERVOUS SYSTEM DRUGS

11. Basic Principles of Neuropharmacology

12. Physiology of the Peripheral Nervous System

13. Muscarinic Agonists

14. Muscarinic Antagonists NEW!

15. Adrenergic Agonists

16. Adrenergic Antagonists

17. Indirect-Acting Antiadrenergic Agents

UNIT V: CENTRAL NERVOUS SYSTEM DRUGS

18. Introduction to Central Nervous System Pharmacology

19. Drugs for Parkinson Disease

20. Drugs for Alzheimer Disease

21. Drugs for Seizure Disorders

22. Drugs for Muscle Spasm and Spasticity

UNIT VI: DRUGS FOR PAIN

23. Local Anesthetics

24. Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics

25. Drugs for Headache

UNIT VII: PSYCHOTHERAPEUTIC DRUGS

26. Antipsychotic Agents and Their Use in Schizophrenia

27. Antidepressants

28. Drugs for Bipolar Disorder

29. Sedative-Hypnotic Drugs

30. Management of Anxiety Disorders

31. Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder

UNIT VIII: SUBSTANCE USE DISORDERS

32. Substance Use Disorders I: Basic Considerations

33. Substance Use Disorders II: Alcohol

34. Substance Use Disorders III: Nicotine and Smoking

35. Substance Use Disorders IV: Major Drugs of Abuse Other Than Alcohol and Nicotine

UNIT IX: DRUGS THAT AFFECT THE HEART, BLOOD VESSELS, BLOOD, AND BLOOD VOLUME36. Review of Hemodynamics

37. Diuretics

38. Drugs Acting on the Renin-Angiotensin-Aldosterone System

39. Calcium Channel Blockers

40. Vasodilators

41. Drugs for Hypertension

42. Drugs for Heart Failure

43. Antidysrhythmic Drugs

44. Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels

45. Drugs for Angina Pectoris

46. Anticoagulant, Antiplatelet, and Thrombolytic Drugs

47. Drugs for Deficiency Anemias

UNIT X: DRUGS FOR ENDOCRINE DISORDERS

48. Drugs for Diabetes Mellitus

49. Drugs for Thyroid Disorders

UNIT XI: WOMEN'S HEALTH

50. Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications

51. Birth Control

UNIT XII: MEN'S HEALTH

52. Androgens

53. Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia

UNIT XIII: ANTI-INFLAMMATORY, ANTIALLERGIC, AND IMMUNOLOGIC DRUGS

54. Review of the Immune System

55. Childhood Immunization

56. Antihistamines

57. Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs and Acetaminophen

58. Glucocorticoids in Nonendocrine Disorders

UNIT XIV: DRUGS FOR BONE AND JOINT DISORDERS

59. Drug Therapy of Rheumatoid Arthritis

60. Drug Therapy of Gout

61. Drugs Affecting Calcium Levels and Bone Mineralization

UNIT XV: RESPIRATORY TRACT DRUGS

62. Drugs for Asthma and Chronic Obstructive Pulmonary Disease

63. Drugs for Allergic Rhinitis, Cough, and Colds

UNIT XVI: GASTROINTESTINAL DRUGS

64. Drugs for Peptic Ulcer Disease

65. Laxatives

66. Other Gastrointestinal Drugs

UNIT XVII: NUTRITION AND COMPLIMENTARY THERAPIES

67. Vitamins

68. Drugs for Weight Loss

69. Complementary and Alternative Therapies

UNIT XIII: THERAPY OF INFECTIOUS AND PARASITIC DISEASES

70. Basic Principles of Antimicrobial Therapy

71. Drugs That Weaken the Bacterial Cell Wall I: Penicillins

72. Drugs That Weaken the Bacterial Cell Wall II: Other Drugs

73. Bacteriostatic Inhibitors of Protein Synthesis

74. Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis

75. Sulfonamides and Trimethoprim

76. Drug Therapy of Urinary Tract Infections

77. Drugs Therapy for Tuberculosis

78. Miscellaneous Antibacterial Drugs

79. Antifungal Agents

80. Antiviral Agents I: Drugs for Non-HIV Viral Infections

81. Antiviral Agents II: Drugs for HIV Infection and Related Opportunistic Infections

82. Drug Therapy of Sexually Transmitted Diseases

83. Anthelmintics, Antiprotozoal Drugs, and Ectoparasiticides

UNIT XIX: CANCER THERAPY

84. Introduction to Immunomodulators NEW!

85. Supportive Care of Patients Receiving Anticancer Drugs

86. Drugs for Cancer Pain

UNIT XX: Drugs for Eyes, Ears, and Skin

87. Drugs for the Eye

88. Drugs for the Skin

89. Drugs for the Ear

UNIT XXI: DRUG THERAPY IN ACUTE CARE

90. Agents Affecting the Volume and Ion Content of Body Fluids

91. Management of ST-Elevation Myocardial Infarction

92. Additional Acute Care Drugs

APPENDIX: Canadian Drug Information